# An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders

> **NCT01811238** · PHASE4 · COMPLETED · sponsor: **Mundipharma Korea Ltd** · enrollment: 240 (actual)

## Conditions studied

- Spinal Disorders

## Interventions

- **DRUG:** Oxycodone/naloxone

## Key facts

- **NCT ID:** NCT01811238
- **Lead sponsor:** Mundipharma Korea Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-07
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2016-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01811238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01811238, "An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT01811238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*